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The accelerated cell death 11 (acd11) mutant of
Arabidopsis provides a genetic model for studying
immune response activation and localized cellular
suicide that halt pathogen spread during infection
in plants. Here, we elucidate ACD11 structure and
function and show that acd11 disruption dramati-
cally alters the in vivo balance of sphingolipid medi-
ators that regulate eukaryotic-programmed cell
death. In acd11 mutants, normally low ceramide-1-
phosphate (C1P) levels become elevated, but the
relatively abundant cell death inducer phytocera-
mide rises acutely. ACD11 exhibits selective inter-
membrane transfer of C1P and phyto-C1P. Crystal
structures establish C1P binding via a surface-local-
ized, phosphate headgroup recognition center con-
nected to an interior hydrophobic pocket that
adaptively ensheaths lipid chains via a cleft-like
gating mechanism. Point mutation mapping con-
firms functional involvement of binding site resi-
dues. A p helix (p bulge) near the lipid binding cleft
distinguishes apo-ACD11 from other GLTP folds.
The global two-layer, a-helically dominated, ‘‘sand-
wich’’ topology displaying C1P-selective binding
identifies ACD11 as the plant prototype of a GLTP
fold subfamily.388 Cell Reports 6, 388–399, January 30, 2014 ª2014 The AuthorsINTRODUCTION
Sphingolipids and their metabolites (i.e., ceramide [Cer], cer-
amide-1-phosphate [C1P], and the long-chain bases [LCBs]
sphingosine and sphingosine-1-phosphate [S1P]), are bioactive
lipids that function as messenger signals and mediators of
eukaryotic processes such as cell growth, development,
embryogenesis, senescence, inflammation, and programmed
cell death (PCD) (Fyrst and Saba, 2010; Hannun and Obeid,
2008; Michaelson and Napier, 2010). The dynamic balance
between Cer (sphingoid base amide linked to a fatty acyl chain)
and its phosphorylated derivative, C1P, critically regulates PCD
in plants and animals (Berkey et al., 2012; Chen et al., 2009; Pata
et al., 2010; Reape and McCabe, 2008).
In plants, PCD occurs during development, during disease
symptoms associated with virulent infections, and during the
hypersensitive response (HR) induced by avirulent stress effec-
tors (Lam, 2004). Hallmarks of HR are local accumulation of
reactive oxygen species, nitric oxide, and the phytohormone,
salicylic acid (SA). By inducing localized cell death triggered
when resistance proteins recognize specific pathogen-derived
molecules, HR potentiates defensive resistance. Mutants exhib-
iting accelerated cell death (acd) phenotypes in the absence of
pathogen effectors also provide insights into HR-like PCD and
defense activation. One HR mimic is the acd5 mutant, which
lacks Cer kinase (CerK) activity and accumulates Cers, triggering
PCD (Liang et al., 2003). C1P addition partially abrogates the
PCD-inducing effects of elevated Cer in acd5. In acd11 null
mutant, HR-related PCD and defense genes are constitutively
activated in a SA-dependent fashion. The acd11 gene encodes
ACD11, a lipid transfer protein able to moderately accelerate
the intermembrane transfer of sphingosine and sphingomyelin
(SM), but not Cer or glycosylceramides (Brodersen et al., 2002;
Petersen et al., 2008).
Structural homology modeling predicts that ACD11 forms a
GLTP fold and is a glycolipid transfer protein (GLTP) superfamily
member (Airenne et al., 2006; Brown and Mattjus, 2007;
Petersen et al., 2008). Yet, ACD11 is unable to transfer glyco-
lipids (Brodersen et al., 2002), consistent with the lack of
essential residues needed for glycosphingolipid (GSL) sugar
headgroup binding (Petersen et al., 2008). In mammalian GLTPs
and HET-C2 fungal GLTP, X-ray structures reveal the molecular
details of how glycolipids are recognized and bound by a
conserved residue cluster (Asp, Asn, Lys, His, and Trp) that
forms a hydrogen bond network with the GSL sugar-amide re-
gion, thus explaining the selectivity and transfer proficiency for
various GSLs (Airenne et al., 2006; Kenoth et al., 2010, 2011;
Malinina et al., 2004, 2006; Samygina et al., 2011). Currently
lacking for ACD11 is the establishment of its preferred sphingo-
lipid ligand as well as direct evidence for its functional involve-
ment in the regulation of plant sphingolipid metabolism.
Herein, we investigated ACD11 structure and lipid transfer
specificity and discovered high selectivity for C1P and phyto-
C1P, but not related plant sphingolipids, i.e., glucosylceramides
(GlcCers), Cer, glycosylinositolphosphoceramides (GIPCs), and
sphingoid LCBs. X-ray structures establish ACD11 global archi-
tecture to be a GLTP fold and reveal the molecular basis for
selective recognition of C1P. Point mutation functional analyses
support structural mapping showing a cationic residue cluster
mediating the selective binding of the C1P headgroup in a sur-
face-located recognition cavity. An intrahelical distortion, i.e., p
helix (p bulge), uniquely distinguishes ACD11 from other known
GLTP folds including the recently discovered human ceramide-
1-phosphate transfer protein (CPTP) (Simanshu et al., 2013).
The p bulge involves key residues of the C1P recognition center
that regulates access and encapsulation of the lipid hydrocarbon
chains to an adjoining hydrophobic pocket. InArabidopsis acd11
(acd11-1) null mutant, normally low C1P levels are elevated,
whereas relatively abundant phytoceramides (phyto-Cers) rise
acutely, consistent with shifts in the dynamic balance and distri-
butions of these two sphingolipids playing a key role in plant PCD
regulation.
RESULTS
ACD11 Forms a GLTP Fold with a Helical p Bulge in Its
Lipid Headgroup Recognition Center
To experimentally establish if ACD11 forms a GLTP fold, we
crystallized wild-type (WT) protein and determined its struc-
ture (1.8 A˚) (Tables S1 and S2). ACD11 adopts the two-layer,
all a-helical ‘‘sandwich’’ motif characteristic of the GLTP fold
(Figure 1A). Nonetheless, there are differences compared to
the human GLTP fold prototype (Figure S1). At the N terminus,
ACD11 has an extra a helix (designated aN) that is lacking in
human GLTP and is35% shorter in human CPTP. Key residues
involved in lipid headgroup recognition in ACD11 (Figure 1B,
cyan) differ in GLTP (Figure 1B, pink), but not in CPTP (Figure 1C,Cbeige), except for conserved Asp60 and His143, residues
needed for Cer interaction in all GLTP folds (Figure S1A, red).
The ACD11 C-terminal region does not directly contribute to for-
mation of the headgroup recognition cavity as occurs in GLTP
(Figure 1B, red arrow) but resembles the HET-C2 fungal GLTP
fold, which terminates similarly with a Trp residue (Kenoth
et al., 2010). In ACD11, C-terminal Trp206 positioning is stabi-
lized by cation-pi interaction with Arg92, but no similar interac-
tion occurs in GLTP or CPTP, which end with Val209 and
Pro214, respectively. A relatively small, compact cavity for lipid
headgroup binding exists in ACD11 and CPTP, a consequence
of the a3/a4 loop projecting out and over in hood-like fashion
(Figure 1B, blue arrow; Figure 1C). The nearby surface region
is highly basic (Figures 1D and 1F) compared to its more neutral
counterpart in human GLTP (Figure 1E). A noteworthy structural
feature of apo-ACD11 is the p helix (p bulge) in helix a2 near
Asp60 resulting in close proximity to His143 via a 2.9 A˚ salt
bridge (Figures 1G and 1J). In all other known apo-GLTP folds
including CPTP, no p bulge occurs, and the analogous Asp
and His residues remain further apart (Figures 1H and 1I).
Crystal Structure of ACD11 in Complex with
Lysosphingomyelin
The first tests of ACD11 transfer of GSL and related metabolites
(Brodersen et al., 2002) preceded crystal structure determination
of the human GLTP fold and mapping of the glycolipid binding
site (Malinina et al., 2004). GLTP and ACD11 superpositioning
(Figure 1B) reveals a positively charged residue triad (K64,
R99, and R103) in ACD11 replacing N52, L92, and W96 in
GLTP. This explains the lack of glycolipid transfer by ACD11
and limited transfer of SM, which has a phosphocholine head-
group (Petersen et al., 2008). Thus, initial trials focused on
cocrystallization of WT-ACD11 complexed with SM and lysos-
phingomyelin (lysoSM) (Figure 2A). Only the latter lipid yielded
a crystal complex enabling 2.4 A˚ resolution (Figures 2B–2D;
Table S1). The expected lipid-headgroup recognition cavity is
occupied by a sulfate ion from crystallization solution. Also
adsorbed nearby on the protein surface is the sphingoid chain
of lysoSM. Notably, the choline headgroup moiety projects out-
ward and away from the protein surface (Figures 2B–2D). One
phosphate oxygen undergoes hydrogen bonding with the amide
nitrogen of Gly144, whereas the sphingoid base amine hydrogen
bondswith Asp60 (Figure 2D). Thep bulge centered at Asp60 (a2
helix) persists in the ACD11/lysoSM complex. At the crystal-
packing interface of the asymmetric unit, an additional lysoSM
molecule is observed (Figure S2A).
ACD11 Is a C1PTP
Because plants contain no SM and do not produce this sphingo-
lipid, SM transfer by ACD11 was surprising, suggesting that SM
serves as a substitute analog for the plant lipid preferred in vivo
(Petersen et al., 2008). Also, as noted earlier, the lipid headgroup
binding cavity is relatively small, compact, and hood-like (Fig-
ure 1B, blue arrow), an arrangement expected to poorly accom-
modate the bulky SM phosphocholine headgroup. With that
in mind, WT-ACD11 was analyzed for intermembrane transfer
of other sphingolipids and phosphoglycerides. A Fo¨rster reso-
nance energy transfer approach involving probe lipids withell Reports 6, 388–399, January 30, 2014 ª2014 The Authors 389
Figure 1. Crystal Structure of Arabidopsis
ACD11, Comparison with Human GLTP
and CPTP Structures, and p Bulge in
ACD11 Lipid Headgroup Binding Pocket
(A) GLTP fold of apo-ACD11 (ribbon) showing
arrangement of a helices (cyan) and 310 helices
(lavender).
(B) Structural superposition of ACD11 (cyan) and
human GLTP (pink) comparing side chains (stick
representation) involved in lipid headgroup
recognition. Blue and red arrows show insertion
loop in ACD11 (lavender highlights) and human
GLTP (red highlights), respectively, near the lipid
headgroup binding pocket.
(C) Structural superposition of ACD11 (cyan) and
mouse CPTP (tan) comparing side chains (stick
representation) involved in phosphate headgroup
recognition.
(D) ACD11 surface electrostatics showing posi-
tively charged region around the lipid headgroup
binding cavity. Blue indicates positive charge.
(E) Surface electrostatics of human GLTP bound
to 18:1 LacCer (stick representation) showing
larger, neutral (white) cavity for binding lipid sugar
headgroup.
(F) Surface electrostatics of humanCPTP bound to
C1P (stick representation).
(G) p bulge centered on Asp60 promotes salt
bridge formation between Asp60 (a2 helix) and
His143 (a5/a6 loop).
(H) In human apo-GLTP, there is no p bulge
centered on Asp48, and interaction with His140
occurs via water bridging.
(I) In mouse CPTP, there is no p bulge centered on
Asp56 and no water-mediating interaction with
His152.
(J) Stereo view of p bulge in ACD11 a2 helix.
Hydrogen bond types i/i-4 and i/i-5 are shown
as black and pink dashed lines, respectively.
Interactions among Asp60 and neighboring
His143, Lys64, and a water molecule are shown as
green dashed lines.
See also Figures S1 and S7 and Tables S1, S2,
and S3.acyl-linked anthrylvinyl (AV) fluorophore enabled testing of lipids
with phosphate headgroups, i.e., AV-phosphatidic acid (AV-PA)
and AV-C1P, and controls, i.e., AV-galactosylceramide (AV-
GalCer), AV-SM, and AV-Cer. ACD11 robustly transferred AV-
C1P (sphingoid based), but not AV-PA (glycerol based) (Figures
2E and 2F). Notably, ACD11 also transferred AV-phyto-C1P (Fig-
ures 2E and 2F), as expected bymodeling of phyto-C1P docking390 Cell Reports 6, 388–399, January 30, 2014 ª2014 The Authorsin the ACD11 binding site. The sphingoid
chains of ‘‘phyto’’ sphingolipid deriva-
tives that predominate in plants lack
the 4,5 trans double bond but contain a
4-hydroxy group (Markham et al., 2006,
2013). The AV-C1P and AV-phyto-C1P
transfer rates depended on protein
concentration, required acceptor mem-
branes (Figures 3B, S3A, and S3B), and
proceeded at 4.5 C1P and 5.6
phyto-C1P molecules/min/protein. Replacement of phosphate
with sugar (AV-GalCer) prevented transfer by ACD11, but not
by GLTP. AV-SM transfer by ACD11 was very slow (Figure 2E).
The lack of AV-Cer transfer suggested a requirement for phos-
phate in the headgroup for functionality. This was confirmed
by competition against AV-C1P transfer by lipids containing nat-
ural hydrocarbon chains (Figure 2G). Only nonfluorescent C1P
A B C D
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Figure 2. Crystal Structure of ACD11 in Complex with lysoSM and ACD11 Lipid Transfer Specificity
(A) Structure of lysoSM.
(B) Crystal structure of ACD11/lysoSM complex showing ACD11 (ribbon) bound to lysoSM and sulfate (space filling).
(C) Surface electrostatics of ACD11 in complex with lysoSM.
(D) Lipid headgroup recognition center residues (lavender) interacting with lysoSM (blue, ball-and-stick) and sulfate. Dashed lines show hydrogen bonds.
(E) Lipid transfer in vitro by Fo¨rster resonance energy transfer.
(F) Quantification of initial lipid transfer rates in (E).
(G) Competition against AV-C1P transfer by nonfluorescent lipids. 18:1-C1P competes strongly, lysoSMmoderately, S1P weakly, and IPC nearly nil (see Figures
S3C–S3F for kinetic traces).
See also Figures S2 and S3 and Tables S1 and S3.competed strongly against AV-C1P (Figure S3C). IPC (inositol-
phosphoceramide), S1P, lysoSM, and N-hexyl(6:0)-SM (data
not shown) exerted differing weak competition (Figures 2G and
S3D–S3F). PA and lysoPA minimally slowed the initial AV-C1P
transfer rate and were not effective competitors (Figure S3G).
Crystal Structure of D60N/D60A-ACD11 with
Bound C1P
Due to the high transfer specificity for C1P, extensive cocrystal-
lization trials were initiated for WT-ACD11 and C1P, but no pos-
itive outcome ensued. To achieve success, a point mutation
strategywas used toweaken the Asp60-His143 salt bridge asso-
ciated with the p bulge. We focused on Asp60 becausemutation
of the analogous Asp (D48V) in human GLTP is reasonably well
tolerated (Samygina et al., 2011). Asp60wasmutated to residues
expected to weaken (Asn) or eliminate (Ala) salt bridging with
H143. The D60N-ACD11 mutant maintained 25%–30% activ-
ity, whereas D60A-ACD11 was 10%–15% active compared
to WT-ACD11 (Figure 3B).
Both the D60N and D60A mutants yielded crystal complexes
with N-dodecanoyl-C1P (12:0-C1P) (Figure 3; Tables S1 andCS3), but not with other lipids (e.g., S1P, sphingosine, SM,
lysoSM, or PA). In the D60N-ACD11/12:0-C1P crystal complex,
the asymmetric unit consists of two ACD11 molecules contain-
ing 12:0-C1P bound in two ways (Figures 3C–3F). In one case,
both the sphingosine and lauroyl acyl chain of 12:0-C1P are
encapsulated in the hydrophobic pocket (Figures 3C and 3E).
In the other case, only the lauroyl acyl chain is inserted into the
hydrophobic pocket, whereas the sphingosine chain remains
outside the pocket (Figures 3D and 3F). With D60A-ACD11/
12:0-C1P complex, a different crystal form was observed
involving one protein molecule with bound 12:0-C1P (Figure 3G;
Tables S1 and S3). However, the overall structure resembled the
sphingosine-out binding mode displayed by D60N-ACD11/12:0-
C1P complex (Figures 3G and 3H). Similar sphingosine-out con-
formers have been observed in human GLTP complexed with
GSLs (Malinina et al., 2006; Samygina et al., 2011, 2013) and in
human CPTP complexed with C1P (Simanshu et al., 2013).
Similar positioning of different C1P species occurs in the hydro-
phobic pockets of ACD11 and CPTP except for the obvious
differences in the bending angle of the outwardly projecting
sphingoid chain in the sphingosine-out bindingmode (Figure S4).ell Reports 6, 388–399, January 30, 2014 ª2014 The Authors 391
Figure 3. Crystal Structures of D60N/D60A-
ACD11 in Complex with 12:0-C1P and Their
C1P Transfer Activities
(A) Structure of 12:0-C1P.
(B) C1P initial transfer rates by WT-ACD11 (red),
D60N-ACD11 (green), and D60A-ACD11 (blue)
using 3 mg each.
(C) D60N-ACD11 (ribbon) in complex with 12:0-
C1P showing the acyl and sphingosine chains
both buried in the hydrophobic pocket (sphingo-
sine-in mode; space filling) in one molecule of the
crystal asymmetric unit.
(D) D60N-ACD11 (ribbon) in complex with 12:0-
C1P (space filling) with the acyl chain buried in the
hydrophobic pocket and the sphingosine chain
adsorbing to the protein surface (sphingosine-out
mode) in the second molecule of the crystal
asymmetric unit.
(E) Surface electrostatics of D60N-ACD11 with
bound 12:0-C1P (sphingosine-in mode; ball-and-
stick).
(F) Surface electrostatics of D60N-ACD11 with
bound 12:0-C1P (sphingosine-out mode).
(G) Structural superposition of C1P headgroup
binding pocket of D60N-ACD11 (green) and D60A-
ACD11 (yellow) in complex with 12:0-C1P showing
the disappearance of p bulge in a2 helix.
(H) Structural comparison of 12:0-C1P binding
to D60N-ACD11 (sphingosine-in, magenta and
sphingosine-out, green) and to D60A-ACD11
(sphingosine-out, yellow).
See also Figures S4 and S7 and Tables S1 and S3.The bending of sphingosine occurs immediately distal to the
4,5 trans double bond where carbon-carbon single bonds exist
and torsional rotation is unrestrained, providing conformational
optimization for packing at the crystal contact faces of ACD11
and CPTP.
Recognition of C1P by ACD11
It is noteworthy that the p bulge in apo-ACD11 (helix a2) disap-
pears upon binding of C1P in both D60N- and D60A-ACD11,
presumably reflecting C1P-induced conformational changes
related to portal opening and entry of one or both C1P hydrocar-
bon chains into the hydrophobic pocket (Figures 3G, 4A, and
4B). In both 12:0-C1P conformer complexes with D60N- and
D60A-ACD11, the C1P group is anchored to positively charged
residues on the protein surface via interaction of the three phos-
phate oxygen atoms with Lys64, Arg99, and Arg103 (Figure 4C).
Their functional importance is illustrated by severe reductions
in C1P transfer for the K64A, R99E, R99A, and R103A point
mutants (Figure 4F). The C1P amide moiety hydrogen bonds
with His143 and Asn60. The net effect is disruption of the stabi-
lizing salt bridge and elimination of the p bulge characteristic of
apo-ACD11.392 Cell Reports 6, 388–399, January 30, 2014 ª2014 The AuthorsThe hydrophobic pocket that accom-
modates the sphingosine and acyl chains
of C1P is formed by a cluster of nonpolar
residues, i.e., Leu, Val, Ile, Phe, Met, Ala,
and Tyr, that line the two layers of the ahelices in ACD11 (Figure 4D). Insertion and encapsulation of
the 12:0-C1P hydrocarbon chains result in the disappearance
of the intrahelical p bulge. This p helix-to-a helix structural tran-
sition involves large conformational changes for the side chains
of several residues, i.e., Phe47, Phe54, Phe56, and Leu50 (Fig-
ure 4E), which move toward the protein surface. This effectively
expands the hydrophobic pocket and creates space to accom-
modate the hydrocarbon chains of 12:0-C1P. Introduction of
polarity into the hydrophobic pocket by point mutation (F47Q-
ACD11) leads to diminished activity (Figure 4F), affirming the
importance of the hydrophobic environment. In the ‘‘sphingo-
sine-out’’ structures, the nonpolar amino acids between helices
a5 and a6 interact with the sphingoid chain via hydrophobic and
van der Waals interactions enabling adsorption to the protein
surface when encapsulation by the hydrophobic pocket does
not occur.
Crystal Structure of D60A-ACD11 in Complex with
N-Acetyl-C1P
To define C1P features that contribute to the p helix-to-a
helix transition needed for C1P chain insertion into the hydro-
phobic pocket, D60A-ACD11 was cocrystallized with bound
Figure 4. p Helix Transition to a Helix
Induced by C1P Binding in D60N-ACD11
and Mapping of C1P Binding Site
(A) Stereo representation of a2 helix in the
D60N-ACD11/12:0-C1P crystal complex showing
absence of p bulge.
(B) Stereo view of structural superposition of a2
helix observed in apo-ACD11 (cyan) forming a p
bulge and in D60N-ACD11 (salmon) in complex
with 12:0-C1P structure without a p bulge. For
clarity, only side-chain atoms of Asp60 andHis143
are shown.
(C) 12:0-C1P and amide interactions with
D60N-ACD11 residues in the headgroup binding
cavity. Hydrogen bonds are shown by dashed
lines.
(D) ACD11 residues forming the hydrophobic
pocket that accommodates the C1P acyl and
sphingosine chains.
(E) Localized conformational changes in apo-
ACD11 and D60N-ACD11. Structural super-
position of apo-ACD11 and D60N-ACD11/12:0-
C1P complex shows residues undergoing large
conformational changes during accommodation
of C1P hydrocarbon chains. Bound C1P atoms
(ball-and-stick) are colored magenta, red, and
blue for carbon, oxygen, and nitrogen, respec-
tively. apo-ACD11 and D60N-ACD11 side chains
are colored cyan and salmon, respectively.
(F) C1P intervesicular transfer by ACD11 point
mutants measured using Fo¨rster resonance
energy transfer.N-acetyl(2:0)-C1P (Figures 5A–5E; Tables S1 and S3). As ex-
pected, the phosphate headgroup hydrogen bonds with Lys64,
Arg99, and Arg103, but the bidentate hydrogen bonding of
Arg99 observed with 12:0-C1P (Figure 4C) is reduced to a
single hydrogen bond (Figure 5C). The acetyl chain amide group
is unable to hydrogen bond with Ala60 and fails to hydrogen
bond with His143 (Figure 5C), leaving the acetyl group on
the surface, turned away from Ala60 and outside the hydropho-
bic pocket. The sphingosine chain also remains outside the
hydrophobic pocket (Figures 5B and 5E), adsorbed between
helices a5 and a6 on the protein surface. In this altered ‘‘binding
state,’’ the p bulge persists, suggesting that transitioning of p
helix to a helix is enhanced when the C1P acyl chain is
long enough to enter the hydrophobic pocket (Figure 5D).
From the functional standpoint, N-acetyl-C1P competes poorly
against AV-C1P transfer by ACD11 (Figure 5F), as also is theCell Reports 6, 388–399case for S1P (Figure 2G). By contrast,
N-acetyl-C1P competes moderately well
against CPTP-mediated AV-C1P transfer
(Simanshu et al., 2013), and the structure
of the CPTP/N-acetyl-C1P complex
shows no missing hydrogen bond inter-
actions with the C1P-amide region,
proper engagement of the N-acetyl group
in the binding cleft, and encapsulation of
the sphingoid chain in the hydrophobic
pocket. The differences in position andconformation of bound N-acetyl-C1P molecules in ACD11 and
CPTP are shown in Figure S5.
Perturbations of Sphingolipid Levels in acd11-1Mutants
To elucidate whether ACD11 involvement in Arabidopsis PCD
manifests itself by altering sphingolipid metabolism, sphingolipid
levels were profiled in dying leaves of homozygous acd11-1
mutants. An overall accumulation of total sphingolipids (Fig-
ure 6A) including LCBs (Figure S6A) is evident in acd11
compared to the Landsberg erecta (Ler) WT background, with
total free Cers showing the greatest elevation. In plants, the
dominant Cer species (>90%) are phyto-Cers (Markham et al.,
2006, 2013), which reportedly are more potent inducers of
PCD than Cer (Hwang et al., 2001). To verify and differentiate
between effects caused by spontaneous cell death and reduced
growth in acd11, we monitored sphingolipid levels upon PCD, January 30, 2014 ª2014 The Authors 393
Figure 5. Crystal Structure of D60A-ACD11
in Complex with N-acetyl-C1P
(A) Structure of 2:0-C1P.
(B) Crystal structure of D60A-ACD11 (ribbon rep-
resentation) in complex with 2:0-C1P (space filling)
in sphingosine-out conformation.
(C) Inverted (flipped) orientation of lipid amide-
acetyl group in sphingosine-out binding mode of
2:0-C1P complexed with D60A-ACD11.
(D) Enlarged view of a2 helix showing p bulge in
the superposed structures of apo-ACD11 and
D60A-ACD11 in complex with 2:0-C1P.
(E) Surface electrostatics of D60A-ACD11/2:0-
C1P complex (stick representation).
(F) Competition against ACD11-mediated AV-C1P
transfer by 2:0-C1P.
See also Figure S5 and Tables S1 and S3.induction in acd11/NahG plants at 0, 12, 24, 72, and 120 hr
after treatment with benzo(1,2,3)thia-diazole-7-carbothioic acid
(BTH), a SA analog. Introduction of the bacterial transgene
NahG into the acd11 background removes endogenous SA
needed for development of the cell death phenotype. When
acd11/NahG plants are then treated with BTH, cell death is fully
reinstated. By 72 and 120 hr after BTH treatment (Figure 6B), a
large increase in total Cer is evident compared to Ler and
NahG controls, as well as a minor rise in 2-hydroxyceramide,
which may reflect free Cer hydroxylation or increased sphingoli-
pid turnover. In contrast, levels of GlcCer and GIPC remain
largely unaltered (Figure 6B), suggesting that their increase in
acd11 (Figure 6A) is probably due to reduced growth or the dwarf
phenotype. Changes in levels of LCB(P), i.e., sphingoid-1-phos-
phates, also are insignificant in acd11 (Figure S6B) and, thus,
may take more time or require stronger inductive conditions
(e.g., higher BTH/SA levels) to develop. C1P, which occurs at
extremely low levels at normal growth temperature, was not
detected. The observed perturbations of sphingolipid levels
reveal Cer accumulation during development of acd11 cell
death, suggesting that ACD11 mediates Cer synthesis in a SA-
dependent manner.
Because cold temperature treatment of Arabidopsis induces
substantial and rapid elevation of C1P and LCB(P) by a transduc-
tion process regulated by endogenous nitric oxide (Cantrel et al.,
2011), the responses of C1P and related sphingolipids to
reduced temperature were analyzed in the acd11 background.
Figure 7A shows that acd11 loss of function results in 3- to
5-fold elevations in the levels of different C1P species of plants
subjected to cold treatment. These are quantitative determina-
tions of C1P mass levels in plants, which were previously
detected by radiolabeling (Cantrel et al., 2011). Also evident
are moderate increases in LCBP, but not LCB (Figure 7B), and394 Cell Reports 6, 388–399, January 30, 2014 ª2014 The Authorsdramatic elevations of phyto-Cers (Fig-
ure 7C). Interestingly, with phyto-Cer,
the palmitoyl (16:0) species and very
long acyl species (22–26 carbons) are
most affected, whereas the elevations
with C1P are shifted to the moderately
long acyl species (16–22 carbons). Thesechanges are consistent with a complex regulatory mechanism
involving ACD11.
DISCUSSION
Unique Structural Aspects of the Lipid Headgroup
Recognition Center and Hydrophobic Pocket of the
ACD11 GLTP Fold
Despite low sequence homology of ACD11 and other GLTP
homologs including human CPTP (Figure S1A), our crystallo-
graphic data establish the conserved structural homology
shared by Arabidopsis ACD11, human GLTP, and human
CPTP (Simanshu et al., 2013) while revealing important differ-
ences. Unlike GLTP but like CPTP, ACD11 contains a modified
lipid headgroup recognition center that selectively binds C1P,
an important signaling lipid linked to cell survival. Comparison
of ACD11, GLTP, and CPTP with their preferred bound lipids
suggests adaptation and evolutionary conservation of key
residues in their GLTP folds. The net outcome is two divergent
subfamilies within the GLTP superfamily. Residues adapted to
focus lipid specificity to C1P in ACD11 include Lys64 for
Asn52, Arg99 for Leu92, and Arg103 for Trp96 in GLTP. The clus-
tered Lys/Arg residues of ACD11 form a positively charged triad
that is ideally arranged for binding phosphate, explaining the
inability of ACD11 to bind sugar headgroups and transfer glyco-
lipids (Petersen et al., 2008). It is noteworthy that Arg103
occupies the same position where Trp acts as a stacking plate
for the Cer-linked headgroup sugar in human GLTP, fungal
HET-C2, plant GLTP1, and human FAPP2 (Kamlekar et al.,
2013; West et al., 2008). Conversely, residues analogous to
Asp60 andHis143 of ACD11 are absolutely conserved in the lipid
headgroup recognition centers of all known GLTP folds. The
‘‘pincher-like’’ clamping that occurs when Asp and His hydrogen
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Figure 6. Constitutive and Inducible Alter-
ations in Sphingolipid Content of acd11
Mutants Grown at Normal Temperature
(A) Sphingolipids in leaves of dying acd11-1 plants
compared to the Ler WT control. Data are shown
as four sphingolipid classes including phyto and
nonphyto species: Cer, hydroxyceramides (hCer),
GlcCer, and GIPCs. Data represent the mean ± SD
(n = 3), and significant differences from the
control are indicated by asterisks (**p < 0.01 and
*p < 0.05) on the basis of a Student’s t test. dw,
dry weight.
(B) Sphingolipid contents in leaves of acd11-1/
NahG plants 0, 12, 24, 72, and 120 hr after BTH
treatment in comparison with Ler NahG and
WT controls. Plants were grown for 5 weeks prior
to BTH treatment. Sphingolipid contents are
shown as in (A). Data represent the mean ± SE
(n = 3), and letters indicate statistically different
groups using one-way ANOVA with groupings
by Tukey’s HSD with a 95% confidence interval.
**p < 0.01.
See also Figure S6.bond with the Cer moiety amide nitrogen and oxygen ensures a
highly conserved and oriented entry of the sphingolipid hydro-
carbon chains into the hydrophobic pocket regardless of lipid
headgroup composition. The X-ray data rectify earlier 3D homol-
ogy modeling involving identification of key residues of the
ACD11 lipid headgroup recognition center and location of the
C terminus, i.e., Trp206 (Airenne et al., 2006).
A unique feature of the apo-ACD11 GLTP fold in comparison
to other known GLTP folds including CPTP is the presence of
p helix, i.e., p bulge, in helix a2 near the entrance portal of the
lipid binding cleft (Figures 1G and 1J). p bulges exist in only
15%of known proteins but often at locations that enhance/regu-
late function (Cartailler and Luecke, 2004; Cooley et al., 2010).
The p bulge in apo-ACD11 brings Asp60 and His143 sufficiently
close (2.9 A˚) to form a salt bridge (Figure 1G), thus providing a
potential regulatory mechanism for the ACD11 GLTP fold. In
other GLTP folds, a water molecule often bridges the Asp and
His residues (Figure 1H). In apo-ACD11, the Asp60-His143 salt
bridge created by the p bulge appears to tightly seal the entry
portal region of the hydrophobic pocket (Figure 1G). In D60A-
ACD11, the p bulge persists after binding 2:0-C1P, but not
12:0-C1P, suggesting that salt bridge disruption between
Asp60 and His143 by itself is insufficient to induce the p helix-
to-a helix conformational change needed for the ACD11/C1P
complex to become ‘‘transfer viable.’’ In addition, the C1P acyl
chain needs to be longer than only two carbons. This conclusion
is supported by the structure of WT-ACD11 complexed with
lysoSM, which has no acyl chain but displays a bound conforma-
tion resembling that of 2:0-C1P in D60A-ACD11 (Figures 5 and
S2C). LysoSM is tethered to the surface via its amine group inter-
acting with Asp60, whereas a sulfate anion occupies the lipid
headgroup (phosphate) binding pocket lending credence to the
authenticity of the lysoSM binding site. Analogous behavior is
observed in human GLTP/hexyl glucoside crystal complexes
where the sugar headgroup occupies the glycolipid recognitionCcenter despite weak binding affinity and no measurable transfer
(Malinina et al., 2006; Zhai et al., 2009). In the ACD11/lysoSM
complex, occupation of the phosphate headgroup recognition
center by the sulfate anion and the bulky, zwitterionic nature of
the phosphocholine lipid headgroup are likely contributors to
its minimal interaction and outward projection from the protein
(Figure S2A). Similar conformation and surface localization are
observed for the 2:0-C1P sphingosine chain in complex with
D60A-ACD11 (Figure S2). Thus, despite seemingly adequate
positioning on the ACD11 surface, p bulge persistence renders
the lipid binding interaction insufficient to drive robust transfer.
For ACD11 to become fully ‘‘transfer viable,’’ uptake of the
sphingolipid acyl chain into the hydrophobic pocket and reposi-
tioning of specific residues appear to be required. At the molec-
ular level, p bulge formation at Asp60 results in the Phe56
nonpolar phenyl ring projecting into the hydrophobic pocket to
function as a ‘‘portal gate’’ that swings open during lipid acyl
chain uptake (Figure 4E). Phe54 orients into the hydrophobic
pocket providing conformational stability to apo-ACD11 in the
absence of a lipid acyl chain. When C1P contains a sufficiently
long acyl chain (e.g., 12:0-C1P), the acyl chain enters deep
into the hydrophobic pocket, as shown for D60N-ACD11 and
D60A-ACD11. A ‘‘peristaltic-like shift’’ of Ala57 to occupy the
position of Phe56 as well as Phe54 being pushed outward
accompanies transformation from p bulge to a helix, enabling
hydrophobic pocket formation/expansion sufficient to accom-
modate either one or both hydrocarbon chains of Cer (Figures
4D and 4E). The key role played by Phe56 of helix a2 in func-
tioning as a ‘‘portal gate’’ represents a fundamental difference
between the ACD11 GLTP fold and human GLTP fold, which
uses an ‘‘oppositely located’’ Phe (Phe148 of helix a6) as the
‘‘portal gate’’ that swings open during hydrocarbon chain inser-
tion (Malinina et al., 2004; Samygina et al., 2011). The global
folding topology of ACD11 and conformational adaptability of
its flexible, single-cavity, hydrophobic pocket contrast with Cerell Reports 6, 388–399, January 30, 2014 ª2014 The Authors 395
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Figure 7. Constitutive and Inducible Alter-
ations in Sphingolipid Content of acd11
Mutants in Response to Cold-Temperature
Treatment
(A–C) Sphingolipid contents of acd11, acd11-1/
NahG, and control plants 72 hr after treatment with
BTH. Plants were grown for 5 weeks and sub-
jected to cold (4C) for 4 hr prior to BTH treatment.
(A) C1P. (B) LCB(P). (C) Phyto-Cer. Data represent
the mean ± SE (n = 3), and significant differences
from controls are indicated by asterisks (**p < 0.01
and *p < 0.05) on the basis of a Student’s t test.transfer protein, which uses an a/b fold built around an incom-
plete U-shaped b barrel to bind Cer via a START domain lipid
cavity (Kudo et al., 2008) (see the Supplemental Discussion).
ACD11 Modulates Arabidopsis PCD by Intermediary
Regulation of Sphingolipid Levels
The HR in plants generates localized cell death to minimize the
spread of pathogens. HR-like PCD is also exhibited by the reces-
sive acd11-1 mutant. Despite the known ties between ACD11
and HR-like PCD (Brodersen et al., 2002), determination of the
molecular structure and lipid specificity of ACD11 remained
unclear until now. Establishment of ACD11 architecture as a
C1P-selective GLTP fold capable of binding/transferring either
C1P or phyto-C1P at similar rates provides insights into how
this GLTP superfamily member impacts PCD-related processes
regulated by key sphingolipid metabolites. Although fungal
GLTP (HET-C2) and human FAPP2 (C-terminal GLTP-like
domain) have both been implicated in PCD-related processes
(Fedorova et al., 2005; Paoletti and Clave´, 2007; Tritz et al.,
2009), no sphingolipid analyses were performed upon in vivo
depletion of these glycosylceramide-selective GLTP folds.
Compared to mammals, plant membranes show fundamental
differences in sphingolipid content including large contributions
by GlcCer, GIPC, and modified sphingoid chains (e.g., phyto-
derivatives) as well as a lack of SM and gangliosides (Markham
et al., 2006, 2013; Pata et al., 2010). Adjustment to major lipid
content during cold acclimation is well established in plants.
Recent studies also show rapid elevations of low-level LCB(P)s396 Cell Reports 6, 388–399, January 30, 2014 ª2014 The Authorsand C1P (Cantrel et al., 2011). The estab-
lished signaling functions of such lipids
make them leading candidates as early
signals during cold acclimation. Because
LCB(P) and C1P content is low under
both normal and cold-stressed growth
conditions, initial detection was accom-
plished by radiolabeling (Cantrel et al.,
2011). Determination of LCB(P) and C1P
derivative mass levels has been chal-
lenging, a situation exacerbated by a
dearth of authentic standards (Markham
and Jaworski, 2007). This has been espe-
cially true for C1P derivatives, which had
not been mass quantified in plants until
the present study.Our finding that acd11 deficiency not only alters C1P levels but
also acutely elevates phyto-Cer levels (and LCBP to a lesser
extent) establishes a functional link between acd11 expression
and sphingolipid metabolic regulation in plants where the
dynamic balance between Cer and C1P appears to be critical
for regulating PCD (Chen et al., 2009; Liang et al., 2003; Pata
et al., 2010; Reape and McCabe, 2008). Although elevated
C1P levels induced by acd11 disruption in Arabidopsis also are
observed upon RNAi-induced depletion of the ACD11 ortholog
CPTP in human cells, it is noteworthy that the dramatic eleva-
tions in phyto-Cer levels in acd11 mutants are not duplicated
in the Cer levels of CPTP-depleted human cells (Simanshu
et al., 2013). This suggests some differing aspects of ACD11
involvement in the regulation of sphingolipid metabolism in
plants. Elucidating the mechanistic details and associated
kinetics of this involvement will first require detailed analyses
of plant sphingolipid metabolic pathways, related regulatory sig-
naling pathways, and changes triggered during cold acclimation.
What is known is that the acd5 mutant lacks CerK activity,
accumulates Cers, and exhibits PCD (Liang et al., 2003).
ACD11 may act in concert with ACD5 (CerK) to maintain the bal-
ance of Cer and C1P levels, thus controlling HR-associated
PCD. In this context, the loss of IPC synthase activity (erh1
mutant) also results in total Cer accumulation, and both erh1
and acd5 exhibit enhanced HR-associated cell death triggered
by the RPW8 resistance protein (Wang et al., 2008). However,
Cer accumulation and cell death in acd11, acd5, and erh1
are dependent on the phytohormone, SA. This suggests that
perturbations in sphingolipid metabolism, such as occur in
acd11, may regulate SA levels or signaling during R gene-medi-
ated HR. Plant R proteins confer recognition of pathogen aviru-
lence proteins and trigger effective innate immune responses
(e.g., HR). A genetic screen for suppressors of acd11 cell death
(laz mutants) identified the R gene LAZ5. Thus, the absence of
ACD11 in acd11 leads to inappropriate HR activation by LAZ5
(Palma et al., 2010). Because sphingolipids are important in
both microbial pathogenesis and host defense (Heung et al.,
2006), LAZ5 may ‘‘guard’’ ACD11 function(s) in certain sphingo-
lipid metabolic pathways targeted by pathogen effectors. Also,
transgenic expression of human WT-GLTP and D48V-GLTP
(Petersen et al., 2008) suppresses acd11 cell death, raising the
possibility that the C1P binding/transfer activity of ACD11 is
partially dispensable for PCD suppression. This could implicate
LAZ5 as a response amplifier that triggers the HR when the local
distribution and balance between phyto-Cer and C1P are
disturbed, thereby intensifying the response through SA accu-
mulation. Pathogen effector-induced modification or loss of
function of ACD11 could interfere with normal sphingolipid distri-
bution and trigger a defense response strong enough to deter
microbial colonization. Because sphingolipid bases are upregu-
lated early during an infection or HR, it is probable that sphingo-
lipids are signaling mediators, and not the de facto cell death
inducers via membrane perturbations (Mackey et al., 2003;
Peer et al., 2010). Testing this hypothesis will require research
to clarify the interplay between cellular sphingolipid metabolism
and basal immunity in plants.
It is also possible that loss of ACD11 as a selective carrier
blocks C1P exit from the Golgi resulting in organelle stress, as
occurs in human cells depleted of the ACD11 ortholog, CPTP
(Simanshu et al., 2013), and leading to local accumulation of
Cer that alters membrane component organization. Because
ACD11 may be indirectly guarded (Palma et al., 2010), triggering
of HR cell death may not rely directly on the absence of ACD11
in the acd11 mutant. In mammals, nonmicrobial ‘‘danger sig-
nals’’ instigate obesity-induced inflammation via NLRP3, which
senses increasing Cer and induces apoptosis (Vandanmagsar
et al., 2011), providing a potential clue as to how the HR might
be induced in acd11 by LAZ5 via detection of the accumulation
of specific sphingolipid species. Future localization studies on
ACD11 and LAZ5 to evaluate possible corestriction in specific
organelles could provide more insights.
EXPERIMENTAL PROCEDURES
Cloning, Expression, and Purification
acd11-1 open reading frame (ORF; GenBank accession number NCBI
NP_181016.1) expression in BL21(DE3) pLysS cells using pET-SUMO vector
(Invitrogen) enabled Ni2+-NTA affinity chromatography purification of ACD11
N-terminally tagged with His6-SUMO (see Supplemental Experimental Proce-
dures). Pure proteins were either used for crystallization immediately or flash
frozen in liquid N2 and stored at 80C. ACD11 mutants were generated by
PCR-based overlap extension and confirmed by DNA sequencing. Expres-
sion/purification was the same as for WT-ACD11.
Crystallization
A Mosquito crystallization robot (Molecular Dimensions) was used for initial
cocrystallization screening of WT-ACD11 and the D60N and D60A mutants
with lysoSM and C1P species (see the Supplemental Experimental Proce-Cdures). Positive hits were optimized using the hanging drop vapor diffusion
method by varying pH and concentration of individual components (Table
S3). For data collection, crystals were flash frozen (100 K) in crystallization
condition containing 25% (v/v) ethylene glycol. Diffraction data sets were
collected on 24-ID-C and 24-ID-E beamlines at the Advanced Photon Source
and X29A beamline at National Synchrotron Light Source. Collected data sets
were integrated and scaled using the HKL2000 suite (Otwinowski and Minor,
1997). All crystals have different packing interactions leading to different unit
cell dimensions and space groups (Table S1).
Structure Determination and Refinement
Ab initio phasing was obtained by soaking apo-ACD11 crystals in 1 mM ethyl
mercuric phosphate for 24 hr and collecting data (2.45 A˚ resolution) using a
Rigaku RU-H3R X-ray generator equipped with a RAXIS-HTC detector (Table
S2). ACD11 structure was determined by the SIRAS method using Hg isomor-
phous as well as anomalous scattering data, with the 8 Hg sites located and
refined for phasing using SHARP (Vonrhein et al., 2007). apo-ACD11 crystals
belonged to space group P212121 and contained four protein molecules per
asymmetric unit. The structures of ACD11-sphingolipid complexes were
solved by molecular replacement (MOLREP program) using apo-ACD11 (Hg
derivative) structure as the search model (Vagin and Teplyakov, 1997) (see
the Supplemental Experimental Procedures).
ACD11 Intermembrane Lipid Transfer Activity
Fo¨rster resonance energy transfer provided kinetic insights into lipid transfer
by ACD11. Donor POPC vesicles, containing 1 mol% AV-lipid acylated with
(11E)-12-(9-anthryl)-11-dodecenoate and 1.5 mol% 1-acyl-2-[9-(3-peryle-
noyl)-nonanoyl]-3-sn-glycero-3-phosphocholine (Per-PC) were prepared by
rapid ethanol injection (Mattjus et al., 1999). In competition assays, donor ves-
icles contained 1 mol% AV-C1P (Boldyrev et al., 2013) as well as 0.5, 1.0, or
2.0 mol% competitor lipids (Samygina et al., 2011). Both fluorescent lipids
were present initially only in donor vesicles where minimal AV emission occurs
upon excitation (370 nm) because of energy transfer to Per-PC. ACD11 addi-
tion results in an exponential increase in AV emission intensity as the protein
transports AV-C1P from donor vesicles (creating separation from the
‘‘nontransferable’’ Per-PC) and delivers to the 10-fold excess POPC acceptor
vesicles. The time-dependent increase in AV emission at 425 nm, relative to
baseline fluorescence in the absence of ACD11, yields the AV-C1P transfer
kinetics (see the Supplemental Experimental Procedures).
Plant Material and Sphingolipid Analyses
acd11-1, acd11/NahG, and NahG plants in Ler background have been
described by Brodersen et al. (2005). For sphingolipid analyses, plants
were grown in soil under short days (8 hr light/16 hr dark) in chambers at
150 mE/m2s, 21C, and 70% relative humidity. Ler WT and acd11-1 mutants
were grown untreated for 4 weeks before sampling. acd11-1/NahG together
with NahG and Ler plants were grown for 5 weeks prior to spraying with the
SA analog BTH (100 mM) and sampling after 0, 12, 24, 72, and 120 hr. Leaf
material was harvested from three biological replicates for each genotype
and time point. Sphingolipid analysis was performed by mass spectrometry
(Bielawski et al., 2009; Markham and Jaworski, 2007). Free and total LCBs
were analyzed by HPLC after fluorescent derivatization (Bach et al., 2008).
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